ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Oncomed Pharmaceuticals, Inc.

Oncomed Pharmaceuticals, Inc. (OMED)

0.89
0.00
(0.00%)
Closed September 23 4:00PM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.89
Bid
0.9175
Ask
0.89
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.89
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

OMED Latest News

Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, ...

Notice of Preliminary Results THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS...

Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Merger Update: Acquisition of OncoMed Pharmaceuticals, In...

LONDON, April 18, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, announces today that...

OncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rights

REDWOOD CITY, Calif., March 15, 2019 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (“OncoMed”) (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and...

OncoMed Announces Fourth Quarter and Full Year 2018 Financial Results

REDWOOD CITY, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel...

Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals

  To be effected by an all-stock transaction plus issuance of Contingent Value Rights (“CVRs”); completion expected H1 2019 Deal broadens asset and shareholder base and extends Enlarged Group...

OncoMed Announces Early Clinical Data for anti-TIGIT Antibody

Phase 1a Dose-Escalation Data Demonstrates a Favorable Safety Profile and Signals of Immune Cell Modulation in Patients with Late Stage Solid Tumors REDWOOD CITY, Calif. and WASHINGTON, Nov...

OncoMed Announces Third Quarter 2018 Financial Results and Operational Highlights

 -Company continues enrollment in Phase 1b navicixizumab trial following encouraging single agent and interim combination results in ovarian cancer;  -Prepares for presentation of etigilimab...

OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian...

Overall Clinical Benefit Rate of 85%, Partial Response Rate of 42% and Progression Free Survival of 5.4 Months Observed in Patients with > 2 Prior Therapies and/or Prior Bevacizumab REDWOOD...

OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian...

Overall Clinical Benefit Rate of 85%, Partial Response Rate of 42% and Progression Free Survival of 5.4 Months Observed in Patients with > 2 Prior Therapies and/or Prior Bevacizumab REDWOOD...

OncoMed Says Celgene Won't Exercise Option to License Rosmantuzumab

By Stephen Nakrosis OncoMed Pharmaceuticals, Inc. (OMED) said Wednesday Celgene Corp. (CELG) decided not to exercise its option to license rosmantuzumab, and will terminate the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BNZIBanzai International Inc
$ 5.645
(96.01%)
61.39M
ZJYLJin Medical International Ltd
$ 3.975
(50.00%)
1.24M
ANEBAnebulo Pharmaceuticals Inc
$ 2.9001
(39.43%)
78.85k
XPONExpion360 Inc
$ 0.081
(39.18%)
1.46B
AENTAlliance Entertainment Holding Corporation
$ 2.74
(34.31%)
4.23M
GSIWGarden Stage Ltd
$ 1.34
(-82.89%)
26.44M
CRBPCorbus Pharmaceuticals Holdings Inc
$ 19.51
(-62.26%)
12.29M
LGCBLinkage Global Inc
$ 0.4183
(-57.70%)
2.16M
BFIBurgerFi International Inc
$ 0.0855
(-42.27%)
15.05M
SKYESkye Bioscience Inc
$ 3.17
(-42.26%)
5.14M
XPONExpion360 Inc
$ 0.081
(39.18%)
1.46B
NVDANVIDIA Corporation
$ 116.00
(-1.59%)
377.84M
AAPLApple Inc
$ 228.20
(-0.29%)
320.78M
INTCIntel Corporation
$ 21.84
(3.31%)
261.68M
VERBVerb Technology Company Inc
$ 0.0742
(33.45%)
178.65M

Discussion

View Full Feed
janice shell janice shell 3 minutes ago
I don't remember it, but people bash stocks because they're going up even though they're scams.
fuagf fuagf 3 minutes ago
Scientists looked deep beneath the Doomsday Glacier. What they found spells potential disaster for the planet

"West Antarctica Glaciers: Past the Point of No Return"

Related: [yt]6jzDBznWoHc[/yt]
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=1751
Major Profits Major Profits 6 minutes ago
$BNCM: DELEX Acquisition of JMN BROTHERS PHARMA will fuel its Market Growth

https://www.otcmarkets.com/stock/BNCM/news/BNCM-DELEX-Acquisition-of-JMN-BROTHERS-PHARMA-will-fuel-its-Market-Growth?id=453611
BNCM
Lazarus Lazarus 8 minutes ago
Hmmmm... didn't know about this one.
Major Profits Major Profits 9 minutes ago
$BNCM: DELEX Acquisition of JMN BROTHERS PHARMA will fuel its Market Growth

https://www.otcmarkets.com/stock/BNCM/news/BNCM-DELEX-Acquisition-of-JMN-BROTHERS-PHARMA-will-fuel-its-Market-Growth?id=453611
BNCM
Lazarus Lazarus 9 minutes ago
I doubt he will be doing ANYTHING with ACCR -- as far as I know he's just a shareholder.

so remember https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174779695 this post?

I started bashing a stock (about a month ago) being hyped here on iHub and X when
ACCR
Investor2014 Investor2014 14 minutes ago
I should say that since discovery does not appear to have been granted prior to the motion to dismiss the point is moot is this case.

We shall see if the case survives the motion to dismiss, which we can hope it doesn’t.
AVXL
Humbert Humbert 15 minutes ago
Huge news, big things on the horizon
BNCM
Seminole Red Seminole Red 15 minutes ago
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/460196182_541442735064406_9177747313741140771_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=127cfc&_nc_ohc=e3WzFwJIerMQ7kNvgEbRVzA&_nc_ht=scontent-mia3-1.xx&oh=00_AYDJiXxoewIN3GXpgkSigHrefMIqrB2DpqLBAf0JSkFG9A&oe=66F6E7D6
newflow newflow 17 minutes ago
lota why do you ask me for my opinion? you lack the knowledge or you have more than needed?.You are not good for anybody.you are a manipulative personality, probably an accomplice to hedge funds like AAOC.They were kicked on the nuts.
COOP
Scott999 Scott999 21 minutes ago
No they’re rarely met for sure. Just look at Pluristem eh there Zzatt. How many Zzientists does AUPH have zzatty boy? You use that reasoning to invest here too? You still quoting everyone like you always did? You trying to get 200k shares here too, like you did at Pluristem? Did you like going throu
AUPH
north40000 north40000 26 minutes ago
We have experienced three ships in the Regent portion of NCLH—Navigator, Voyager and Mariner. Smaller, quieter ships with no kids under 16 or 18 years old, same as VIK. We were also impressed with many of the same features that are also offered by VIK including food quality and variety of seafood me
NCLH
Golden Cross Golden Cross 26 minutes ago
$XXII Great Looking Bottom Play! Primed for a Nice Bounce Next Week!

🎯 First Target .52, +100%

Chart
https://x.com/CrossStocks/status/1837930696515412080
XXII
Lakota-45 Lakota-45 27 minutes ago
Yeah 'stockinspector' - The Potential is real here, but . . .

this unexpected, extended Quiet Period could cause a sell-off . . .
if Good News doesn't come out soon. With 46m+ on
the offer, . . this could be the week for it !!!

~ $WDLF / Decentral Life
WDLF
Golden Cross Golden Cross 29 minutes ago
$XXII Great Looking Bottom Play! Primed for a Nice Bounce Next Week!

🎯 First Target .52, +100%

Chart
https://x.com/CrossStocks/status/1837930696515412080
XXII
Scott999 Scott999 30 minutes ago
Imagine being the CEO of a pos company that has blown through $420,000,000.00 and has got $320k in revenue for the year. I’m sure his $741k compensation for 2023. That’s on top of his $2.9 million compensation for 2023. Amazing that these guys aren’t in jail.

How that cdmo revenue d
PLUR
rbtree rbtree 35 minutes ago
It is where it is because it is a blatant scam. Check my past posts, janice's, dino's and gitreal's. Zero doubt
STAL
BADALI BADALI 36 minutes ago
https://x.com/thestockguru13/status/1838090051906924926?s=46&t=y7yrqIlNM3fsfWkjz_Q1IQ
IGPK
rbtree rbtree 37 minutes ago
No. STAL is a blatant scam and I have been warning everyone of that for the entire time I have posted here.
STAL
RuudSaltis RuudSaltis 42 minutes ago
My interpretation is that Polariton is given the primeur! Long existing relationship with record breaking cooperation! Nobody of tier1 and Tier2 can object to this. Waiting for more news to come of which a buy out attempt is not excluded in my opinion. Things can move fast!
LWLG
janice shell janice shell 44 minutes ago
The second one. But the first is weird. Cassowaries are dangerous.

https://x.com/SachabhartiyaRW/status/1837923036206715026
Investor2014 Investor2014 46 minutes ago
Nope discovery often happens and obviously so before a motion to dismiss. In fact a motion to dismiss is generally stayed for discovery to complete.

I hope you can see the logic in that, but don’t expect it.
AVXL
zandant zandant 46 minutes ago
Can you not see that much has happened since 2013 and it has all been bad....
IPIX
jeunke22 jeunke22 46 minutes ago
Waiting for a Lightwave’s Tier 1 deal announcement in 2024, mass production of 800 G , 1.6 G PIC’s.
Polariton is a start up with powerful allies ( ETH Zürich, IBM, Nokia) but not a Tier 1.
Yesterday’s announcement and breakthrough achievement is using “ off-the- shelf” micro ring reso
CET
MartinLutherKing MartinLutherKing 47 minutes ago
AGBA Going to fly off the run way FOXO The next Mega Merger$$$
AGBA FOXO

Your Recent History

Delayed Upgrade Clock